GTR 109528172
Bids Are Invited For Acquisition Of Pharmacological Materials
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
109528172
Tendering Authority
Subscribe to view
Tender No
079/2026
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Pharmacological Materials
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
10-03-2026
Closed
Work Detail
(Id112426) Ascorbic Acid, Pharmaceutical Form: Injectable Solution; Concentration: 100Mg/Ml; Presentation Form: Ampoule With 5Ml., (Id115165) Diclofenac Sodium, Pharmaceutical Form: Injectable Solution; Concentration: 25Mg/Ml; Presentation Form: Ampoule With 3Ml., (Id115332) Dexamethasone, Pharmaceutical Form: Elixir; Concentration: 0.5Mg/5Ml; Presentation Form: Bottle With 120Ml., (Id115531) Dexchlorpheniramine (Maleate), Pharmaceutical Form: Tablet; Concentration: 2Mg., (Id115533) Digoxin, 05Mg/Ml; Presentation Form: Bottle With 60Ml., 02/24/2026 - 14:11:40, 02/24/2026 - 14:11:41, (Id116058) Solid Vaseline, Pharmaceutical Form: Ointment; Concentration: 100%; Presentation Form: Packaging With 30G., (Id116311) Ascorbic Acid, Pharmaceutical Form: Oral Solution; Concentration: 200Mg/Ml; Presentation Form: Bottle With 20Ml., (Id116519) Suxamethonium (Chloride), Pharmaceutical Form: Lyophilized Powder For Injectable Solution; Concentration: 100Mg; Presentation Form: Ampoule Bottle., (Id131513) Valsartan, Pharmaceutical Form: Coated Tablet, Concentration: 160Mg., (Id137624) Umeclidinium (Bromide) + Vilanterol (Trifenatate), Pharmaceutical Form: Powder For Oral Inhalation; Concentration: 62.5Mcg + 25Mcg; Supply Unit: Device With 30 Doses., (Id144947) Dapagliflozin + Metformin Hydrochloride, Pharmaceutical Form: Coated Extended Release Tablet; Concentration: 10Mg + 1000Mg., (Id145686) Ustekinumab, Pharmaceutical Form: Injectable Solution; Concentration: 90Mg/Ml; Supply Unit: 1Ml Ampoule Bottle, (Id150405) Upadacitinib, Pharmaceutical Form: Extended Release Tablet, Concentration: 15Mg.
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
998bf35d-84d0-4e0f-aac1-2da18eebaed6.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.